Get started
Author

Amir Mohammad Shabani

Observed name: Amir Shabani
ORCID: 0000-0001-5313-1133
Observed ORCID: 0000-0001-5313-1133
OpenAlex ID: A5024894378
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
2020 · Hamideh Abbaspour Kasgari, Siavash Moradi, et al. · Journal of Antimicrobial Chemotherapy · 91
PDF
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)
2021 · Sara Mobarak, Mehdi Salasi, et al. · Journal of Antimicrobial Chemotherapy · 21
Evaluation of the Effect of Sofosbuvir and Daclatasvir in Hospitalised COVID-19 Patients: A Randomized Double-Blind Clinical Trial (DISCOVER)
2021 · Sara Mobarak, Mehdi Salasi, et al. · SSRN Electronic Journal · 5
Evaluation of the Safety and Efficacy of N-acetylcysteine in the Prevention of Paclitaxel-induced Peripheral Neuropathy: A Randomized, Double-blind, and Placebo-controlled Trial
2018 · Sima Ramezaninejad, Ehsan Zaboli, et al. · Journal of Research in Pharmacy Practice · 5
Evaluation of the Effect of N-acetylcysteine in the Prevention of Colistin Nephrotoxicity in Critically Ill Patients: A Randomized Controlled Trial
2024 · Amir Mohammad Shabani, Ahmad Alikhani, et al. · Journal of Research in Pharmacy Practice · 4
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial.
2021 · Zahra Nekoukar, Shahram Ala, et al. · PubMed · 3
Evaluation of the Safety and Efficacy of N-acetylcysteine in the Prevention of Paclitaxel-induced Peripheral Neuropathy: A Randomized, Double-blind, and Placebo-controlled Trial
2025 · Sima Ramezaninejad, Ehsan Zaboli, et al. · Journal of Research in Pharmacy Practice · 1
QTc Prolongation in a Young Healthy Patient Receiving Citalopram 40 mg
2018 · Fatemeh Sadat Mirfazeli, Amir Shabani · The Primary Care Companion For CNS Disorders · 1
A Survey on the First 100 COVID-19 Patients Admitted to a Referral Center in Northern Iran in Early 2020
2022 · Hamideh Abbaspour Kasgari, Siavash Moradi, et al. · Pharmaceutical and Biomedical Research
Clinical Case Series of Gastrointestinal Symptoms in Patients With Novel Coronavirus 2019 Infection
2021 · Hamideh Abbaspour Kasgari, Amir Mohammad Shabani, et al. · Pharmaceutical and Biomedical Research
PDF
Works count: 11
Citation count: 131
H-index: 4
I10-index: 2
Year
Topic
Type